Baader Bank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,452
Closed -$439K 431
2026
Q1
$439K Sell
7,452
-3,630
-33% -$212K 0.03% 266
2025
Q4
$593K Buy
11,082
+1,229
+12% +$59.1K 0.04% 246
2025
Q3
$427K Sell
9,853
-3,962
-29% -$185K 0.03% 322
2025
Q2
$549K Buy
13,815
+6,951
+101% +$341K 0.04% 237
2025
Q1
$399K Buy
6,864
+2,131
+45% +$124K 0.03% 253
2024
Q4
$268K Sell
4,733
-1,738
-27% -$97.1K 0.02% 285
2024
Q3
$309K Sell
6,471
-144
-2% -$6.75K 0.02% 290
2024
Q2
$260K Buy
+6,615
New +$296K 0.02% 315
2024
Q1
Sell
-142,025
Closed -$7.25M 331
2023
Q4
$7.25M Buy
142,025
+2,961
+2% +$155K 0.53% 48
2023
Q3
$8.07M Buy
139,064
+188
+0.1% +$11.5K 0.54% 60
2023
Q2
$8.88M Sell
138,876
-125
-0.1% -$8.38K 0.45% 88
2023
Q1
$9.63M Buy
139,001
+394
+0.3% +$27.8K 0.49% 75
2022
Q4
$9.97M Sell
138,607
-17,934
-11% -$1.35M 0.48% 78
2022
Q3
$11.1M Buy
+156,541
New +$11.4M 0.72% 27
2022
Q2
Sell
-125,741
Closed -$9.58M 345
2022
Q1
$9.18M Hold
125,741
0.74% 30
2021
Q4
$7.84M Buy
+125,741
New +$7.38M 0.6% 44

Other funds holding BMY

Baader Bank Aktiengesellschaft's BMY Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,452 shares — an estimated $439K sold.

Baader Bank Aktiengesellschaft first reported a position in BMY in Q4 2021 and held it in 16 quarters. The position peaked at $11.1M in Q3 2022. 896 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 7,452 Bristol-Myers Squibb shares in Q2 2026, an estimated $439K.
  • Baader Bank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 16 quarters.
  • Baader Bank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $11.1M in Q3 2022.
  • 896 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.